Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/2012
05/31/2012US20120136006 Cold menthol receptor antagonists
05/31/2012US20120136000 Tri-cyclic pyrazolopyridine kinase inhibitors
05/31/2012US20120135994 Inhibitors of human phosphatidylinositol 3-kinase delta
05/31/2012US20120135990 Iap inhibitors
05/31/2012US20120135970 Compositions for preventing and treating an immune system disorder
05/31/2012US20120135963 Lipidated oxoadenine derivatives
05/31/2012US20120135959 Metalloprotein inhibitors containing nitrogen based ligands
05/31/2012US20120135958 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
05/31/2012US20120135942 Beta-hairpin peptidomimetics
05/31/2012US20120135941 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip
05/31/2012US20120135916 Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
05/31/2012US20120135085 Method and composition for disinfection and purification
05/31/2012US20120135070 Copolymers
05/31/2012US20120135068 Liposome-encapsulated glutathione for oral administration
05/31/2012US20120135067 Vaccine for mycoplasma infection
05/31/2012US20120135044 Instant thickener comprising probiotics for hot or cold foods and beverages to be administered to dysphagic patients
05/31/2012US20120135043 Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
05/31/2012US20120135042 Methods Using Immunomodulatory Compounds For Treatment of Certain Leukemias
05/31/2012US20120135041 Immunosuppressor based on the blockage of tcr-nck interaction
05/31/2012US20120135040 Temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof
05/31/2012US20120135039 Oral Vaccines for Producing Mucosal Immunity
05/31/2012US20120135037 Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
05/31/2012US20120135036 Bacterial composition and its use
05/31/2012US20120135035 Induction of an immune response against dengue virus using the prime-boost approach
05/31/2012US20120135034 Non-Integrating Retroviral Vector Vaccines
05/31/2012US20120135031 Method of enhancing an immune response
05/31/2012US20120135030 Method of Producing Protein-Carbohydrate Vaccines Reduced in Free Carbohydrate
05/31/2012US20120135029 Method for the purification of protein complexes
05/31/2012US20120135027 Proteins used for the diagnosis of lyme borreliosis
05/31/2012US20120135025 Chlamydia antigens and uses thereof
05/31/2012US20120135024 Neisseria meningitidis antigens and compositions
05/31/2012US20120135023 Influenza hemagglutinin and neuraminidase variants
05/31/2012US20120135022 Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essentially consisting of vp3
05/31/2012US20120135020 Ttk peptides and vaccines including the same
05/31/2012US20120135019 Fviii peptides for immune tolerance induction and immunodiagnostics
05/31/2012US20120135017 Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
05/31/2012US20120135016 Induction of neurogenesis and stem cell therapy in combination with copolymer 1
05/31/2012US20120135014 Single nucleotide polymorphisms (snp) and association with resistance to immune tolerance induction
05/31/2012US20120135013 CD45 and Methods and Compounds Related Thereto
05/31/2012US20120135011 Method for in vivo expansion of T regulatory cells
05/31/2012US20120135008 Methods and compositions for targeting polyubiquitin
05/31/2012US20120135003 Anti-ilt7 antibody
05/31/2012US20120134999 PORIN B (PorB) AS A THERAPEUTIC TARGET FOR PREVENTION AND TREATMENT OF INFECTION BY CHLAMYDIA
05/31/2012US20120134997 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
05/31/2012US20120134992 Mesothelin antibody protein fusions and methods of use
05/31/2012US20120134958 Hydroxyethyl starch-containing polypeptide compositions
05/31/2012US20120134957 Latent phase viral interleukin-10-(vii-10) and uses thereof
05/31/2012US20120134956 Colloidal metal compositions and methods
05/31/2012US20120134935 Use of mometasone furoate for treating airway passage and lung disease
05/31/2012US20120132204 Unit dose dry powder inhaler
05/31/2012CA2856101A1 Immunomodulatory compositions
05/31/2012CA2820618A1 Methods of treatment using selective bcl-2 inhibitors
05/31/2012CA2818827A1 Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
05/31/2012CA2817629A1 Salts and crystalline forms of an apoptosis-inducing agent
05/31/2012CA2815935A1 Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium
05/31/2012CA2815029A1 Imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine derivatives as jak inhibitors
05/30/2012EP2457930A1 Modified chaperonin 10
05/30/2012EP2457897A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
05/30/2012EP2457589A1 Reverse targeting lipid vesicle
05/30/2012EP2457585A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/30/2012EP2457581A1 Composition for external preparation for skin
05/30/2012EP2457572A1 Use of atomic quantum clusters (aqcs) in the prevention of cell proliferative disorders, viral infections and autoimmune diseases
05/30/2012EP2456453A1 Therapeutic uses for plants of the capsicum genus
05/30/2012EP2456451A1 Inhibitor of inflammatory conditions
05/30/2012EP2231652B1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
05/30/2012EP2137146B1 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester
05/30/2012EP2123291B1 Use of Lactobacillus amylovorus for treating periodontal diseases by stimulating IgA production
05/30/2012EP1946769B1 Multivalent vaccine composition with reduced dose of Haemophilus influenzae type B
05/30/2012EP1355673B1 Multivalent meningococcal polysaccharide-protein conjugate vaccine
05/30/2012CN202236365U Heath capsule structure
05/30/2012CN1985000B T-cell death-inducing epitopes
05/30/2012CN1886506B Protein expressed in nk cell
05/30/2012CN1852730B Modulators of P-selectin glycoprotein ligand 1
05/30/2012CN1703238B Recombinant intracellular pathogen immunogenic compositions and methods for use
05/30/2012CN102482670A 通过抑制'hsp70-相互作用蛋白的c末端'(chip)的天然反义转录物而治疗chip相关疾病 By inhibiting 'hsp70- interacting protein c-terminal' (chip) of natural antisense transcripts and treat chip-related diseases
05/30/2012CN102482351A Anti-c[epsilon]mx antibodies capable of binding to human mige on b lymphocytes
05/30/2012CN102482349A 抗vegf抗体和其用途 Anti-vegf antibodies and their use
05/30/2012CN102482278A Pyrimidinones as PI3K inhibitors
05/30/2012CN102482257A Apoptosis signal-regulating kinase inhibitors
05/30/2012CN102481376A Immunomodulatory agent-polymeric compounds
05/30/2012CN102481375A Nanocarriers possessing components with different rates of release
05/30/2012CN102481374A Nanocarriers possessing components with different rates of release
05/30/2012CN102481371A 用于治疗家禽的粘性软质凝胶 For the treatment of poultry sticky soft gel
05/30/2012CN102481362A 表皮生长因子受体(egfr)与蛋白酶活化受体2(par2)对肠道通透性的调节 Epidermal growth factor receptor (egfr) and protease-activated receptor 2 (par2) on the regulation of intestinal permeability
05/30/2012CN102481333A Immunity inducer
05/30/2012CN102481309A 包含脂质体包胶的寡核苷酸和表位的免疫刺激性组合物 Immunostimulatory oligonucleotides and compositions containing the epitope encapsulated liposomes
05/30/2012CN102481278A 紫外线损伤减轻组合物 UV damage mitigation compositions
05/30/2012CN102481277A 紫外线损伤减轻口服组合物 UV damage mitigation oral composition
05/30/2012CN102477387A 神虫雄健酒及其制备方法 God insect vigorous wine and its preparation method
05/30/2012CN102477081A 一种新型多肽在干燥综合征诊断中的应用 A novel peptide used in the diagnosis of Sjogren's syndrome
05/30/2012CN102477079A 一种新型多肽在系统性红斑狼疮诊断中的应用 A novel peptide used in the diagnosis of systemic lupus erythematosus
05/30/2012CN102477078A 胸腺体液因子(THF)-γ2改构肽的制备及其药物组合物的用途 Preparation and use of pharmaceutical compositions thymic humoral factor (THF) -γ2 the altered peptide
05/30/2012CN102477065A 一种制备布地奈德的新16,17-缩酮中间体 A method of preparing a new 16,17 budesonide ketal intermediates
05/30/2012CN102477064A 一种制备环索奈德的新的16,17缩酮中间体 A ciclesonide new intermediates for the preparation of 16, 17-ketal
05/30/2012CN102477058A 一种制备布地奈德的新的16,17-二羟基中间体 A process for producing budesonide new 16,17-dihydroxy intermediate
05/30/2012CN102475831A 神虫雄保健品及其制备方法 God insect male health products and its preparation method
05/30/2012CN102475813A 一种治疗湿疹的药物 A treatment for eczema drug
05/30/2012CN102475731A 治疗小儿(轮状病毒、痢疾及疟疾)疾病分子苗药原料 Treatment of children (rotavirus, diarrhea and malaria) disease molecular Miao medicine raw materials
05/30/2012CN102475729A 片仔癀胶囊的检测方法 Detection Pien Tze Huang Capsules
05/30/2012CN102475718A 禽用转移因子可溶性粉剂及其制作工艺和质量检验方法 Avian transfer factor soluble powder with its production process and quality inspection methods
1 ... 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 ... 1172